Exosomes for the diagnosis and treatment of dementia
Authors:
- 11 January 2023
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Psychiatry
- Vol. 36 (2) , 119-125
Abstract
Purpose of review: Dementia is a syndrome with several possible pathologies. To date, definitive methods for diagnosis and treatment of sub-types of dementia have not been established. Emerging evidence suggests that exosomes can provide important information for the diagnosis and treatment of several subtypes of dementia. This article reviews recent studies on the application of exosomes in dementia. Recent findings: Exosomes are involved in the pathogenesis of Alzheimer's disease (AD) and Parkinson's disease (PD) through transporting toxic proteins such as amyloid beta (Aβ), tau, and α-synuclein. Exosomal microRNAs (miR) and proteins reflect the disease state, and therefore, exosomes can be used as diagnostic markers for diseases such as AD, PD, Huntington's disease (HD), vascular dementia (VaD), dementia with Lewy bodies (DLB), and frontotemporal dementia (FTD). Mesenchymal stem cell (MSC)-derived exosomes have been shown to ameliorate disease pathology, and improve cognitive function in AD, PD, and VAD. Summary: Recent studies have shown that exosomes could be novel diagnostic agents for dementia because they contain molecules that could be potential biomarker candidates indicative of the type and stage of dementia. Therapeutic application of exosomes in dementia has revealed that exosomes only, or exosomes loaded with an active pharmaceutical ingredient (API), ameliorate disease phenotype of dementia. Further work is needed to exploit this potential.Keywords
This publication has 76 references indexed in Scilit:
- Huntington disease: new insights into molecular pathogenesis and therapeutic opportunitiesNature Reviews Neurology, 2020
- Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stageAlzheimer's & Dementia, 2020
- Diagnostic and therapeutic potential of exosomes in Alzheimer’s diseaseJournal of Neurochemistry, 2020
- Dementia prevention, intervention, and care: 2020 report of the Lancet CommissionThe Lancet, 2020
- The biology , function , and biomedical applications of exosomesScience, 2020
- Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubationThe Lancet Infectious Diseases, 2020
- Diagnosis and Management of Dementia: ReviewJAMA, 2019
- Causes and Patterns of Dementia: An Update in the Era of Redefining Alzheimer's DiseaseAnnual Review of Public Health, 2019
- A clinicopathological approach to the diagnosis of dementiaNature Reviews Neurology, 2017
- Dementia: timely diagnosis and early interventionBMJ, 2015